May 2017 FDA Recall Drug by Brian P. Richardson
D-1117-2017 - Marketed without an Approved NDA/ANDA; FDA analysis result found product to contain sildenafil, tadalafil and undeclared milk
This Class I drug recall was voluntarily initiated by Brian P. Richardson on May 25, 2017 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda; fda analysis result found product to contain sildenafil, tadalafil and undeclared milk. The product was distributed in TX and the recall is currently terminated.
Recall Number: D-1117-2017
Marketed without an Approved NDA/ANDA; FDA analysis result found product to contain sildenafil, tadalafil and undeclared milk
05-25-2017
08-30-2017
Unknown
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Brian P. Richardson
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Press Release
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
TX
02-10-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
CaverFlo Natural Herbal Coffee, 25 g, supplied in boxes of 10 packets, manufacture for Caverflo Texas Trading -- UPC: 9555671709987
Batch or Lot Expiration Information
Lot# all lots within expiry.